Skip to content

Relapse prevention for smoking cessation.

Relapse prevention for smoking cessation: Testing explicit regulation processes using dismantling designs.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22069
Enrollment
325
Registered
2010-04-28
Start date
2009-12-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking cessation, Relapse prevention, Attentional Retraining

Interventions

ATTENTIONAL RETRAINING: Smokers will receive an internet-based attentional retraining. The training consists of trials in which participants are shown a smoking-related and neutral stimulus on screen.

Sponsors

Maastricht University Medical Center (MUMC+)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Daily smokers, between the age of 18-65, willing to quit individually within one month after they sign in for participation.

Exclusion criteria

Exclusion criteria: 1. Being a non daily smoker; 2. Not being in the age of 18-65 years; 3. Not willing to quit within one month; 4. Using anti-depressiva, sleeping pills, soft or hard drugs; 5. Drinking more than 16 glasses of alcohol; 6. Being dyslectic; 7. Being color blind or not seeing well even with corrections; 8. Not understanding Dutch.

Design outcomes

Primary

MeasureTime frame
Decrease in attentional bias is measured in the last session of the intervention. The bias is measured using attentional bias tasks. The behavioral effects are measured using questionnaires, by asking the participants about their smoking behavior. At the three, six and twelve months follow-up the effects on smoking abstinence are measured using questionnaires.

Secondary

MeasureTime frame
The secondary outcomes are the results of a process evaluation on how the participants experienced participation to the study.

Contacts

Public ContactIman Elfeddali

P.O. BOX 616

iman.elfeddali@gvo.unimaas.nl+31 43 38 82 436

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)